This biotech name is one of Jim Cramer's favorite stocks and he thinks it can go even higher
August 21, 2023 at 10:48 AM EDT
"I think it's going to be worth more," Jim Cramer said Monday after Regeneron got good news from the FDA on its macular degeneration treatment.
